Advanced technologies for studying coronavirus infections
Core B - Technology Core
This study is looking at samples from people with coronavirus to better understand how the virus works and affects the body, with the goal of finding helpful clues for treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11005772 on NIH RePORTER |
What this research studies
This research focuses on utilizing cutting-edge -OMICs technologies to analyze samples from patients infected with the coronavirus. It involves collaboration among leading experts in proteomics, transcriptomics, and viral genetics to understand the virus's behavior and its impact on the host. By processing both in vivo and ex vivo samples, the research aims to identify key factors that influence infection and disease severity, ultimately integrating this data with clinical information to discover potential biomarkers for treatment. Patients' samples will be analyzed to provide insights into the virus's transmission and host response.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have been infected with the coronavirus and are willing to provide samples for analysis.
Not a fit: Patients who have not been infected with the coronavirus or those with unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the identification of new biomarkers for disease severity and potential therapeutic targets for coronavirus infections.
How similar studies have performed: Other research has shown success in utilizing -OMICs technologies to study viral infections, indicating that this approach has the potential for significant findings.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Garcia-Sastre, Adolfo — Icahn School of Medicine at Mount Sinai
- Study coordinator: Garcia-Sastre, Adolfo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.